Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 331Neoplasms 231Prostatic Neoplasms 191Colorectal Neoplasms 149Lung Neoplasms 129Carcinoma, Non-Small-Cell Lung 105Leukemia, Myeloid, Acute 103Pancreatic Neoplasms 90Multiple Myeloma 90Precursor Cell Lymphoblastic Leukemia-Lymphoma 74Glioblastoma 71Brain Neoplasms 70Head and Neck Neoplasms 69Carcinoma, Hepatocellular 68Melanoma 64Squamous Cell Carcinoma of Head and Neck 62Neoplasm Metastasis 58Uterine Cervical Neoplasms 57Ovarian Neoplasms 55Stomach Neoplasms 50Rectal Neoplasms 50Hematologic Neoplasms 50Glioma 49Carcinoma, Renal Cell 47Sarcoma 46Recurrence 46Esophageal Neoplasms 44Myelodysplastic Syndromes 43Endometrial Neoplasms 43Motor Activity 42

Interventions

Tobacco Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Smoking Reduction × 30 days × Clear all
NCT04620915 2026-05-08

Construal Level as a Novel Pathway for Affect Regulation and Cancer Control

University of Oregon

Phase NA Completed
300 enrolled

Smoking Reduction, Neoplasms, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡